Target intelligence / Profile preview

RNA, U6 small nuclear 179, pseudogene (RNU6-179P)

Target
RNU6-179P
Molecular classification
Pseudogene, Non-coding RNA (derived from snRNA gene family; not itself functional[7]), Other
01

Overview

**RNU6-179P** is a human **pseudogene** derived from the U6 small nuclear RNA (snRNA) locus. U6 snRNA itself is a highly conserved, essential component of the spliceosomal machinery and participates in the excision of introns from pre-mRNA as part of the spliceosome[3][1]. However, RNU6-179P is a retrotransposed, non-functional copy of the U6 snRNA gene. Pseudogenes like RNU6-179P are formed by processed retrotransposition mechanisms, often mediated by LINE-1 (L1) elements, and are not transcribed into functional RNAs nor do they participate in canonical snRNP or spliceosome activity[7]. Their presence in the genome mainly reflects historical events of genome evolution and retrotransposition and may serve as markers of L1 activity rather than as functional biological entities[7].\n\nIf you are seeking a therapeutically relevant target, you likely want the **U6 small nuclear RNA** itself, not one of its pseudogenes. The U6 snRNA is crucial for **spliceosome function** and RNA splicing, but no drugs are known to directly target this RNA and it is not conventionally classified as a drug target, enzyme, receptor, or transporter[3][1].

Other names
RNU6-179PRNA, U6 small nuclear 179, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

No known biological function (pseudogenes by definition lack canonical biological activity[7])
04

Disease associations

Other (pseudogenes may mark genome retrotransposition activity but do not have direct disease roles[7])Genomic markers for retrotransposition or genome evolution[7]

Beyond the preview

Go deeper on RNA, U6 small nuclear 179, pseudogene (RNU6-179P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 179, pseudogene (RNU6-179P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call